Related Experiment Video
Updated: May 25, 2026
09:31
Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism
Published on: February 14, 2022
[Continuous propofol perfusion in critically ill children]
S C Agudelo1, S Mencía, A Faro
1Servicio de Cuidado Intensivo Pediátrico Cardiovascular, Fundación Cardioinfantil, Facultad Pontifícia de Medicina, Universidad Javeriana, Bogotá, Colombia.
Medicina Intensiva
|January 17, 2012
Summary
Continuous propofol infusion (2.1 mg/kg/h) provided safe sedation for critically ill children, with no serious adverse events observed. Further research is recommended to fully understand its effects and safety profile in pediatric intensive care.
Area of Science:
- Pediatric Critical Care Medicine
- Pharmacology
- Anesthesiology
Background:
- Sedation is crucial for managing critically ill children.
- Propofol is a widely used anesthetic agent.
- Data on continuous propofol infusion in pediatric intensive care is limited.
Purpose of the Study:
- To describe the use of continuous propofol infusion for sedation in critically ill children.
- To evaluate the safety and efficacy of this sedation method.
Main Methods:
- Retrospective, descriptive observational study.
- Involved pediatric patients in a pediatric intensive care unit.
- Analyzed demographic, clinical, and laboratory data, including adverse effects.
Main Results:
- 32% of patients received continuous propofol infusion (average dose 2.1 mg/kg/h) for an average of 6.7 days.
- No cases of propofol infusion syndrome or serious drug-related adverse effects were reported.
- While some laboratory abnormalities were noted, they were not linked to propofol, and no significant differences in lactate or infection rates were found.
Conclusions:
- Continuous propofol infusion (1-4 mg/kg/h) appears to be a safe option for sustained sedation in critically ill children.
- Further studies are necessary to comprehensively assess propofol's effects and safety profile in this population.
